.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chubb
Dow
Novartis
Cantor Fitzgerald
UBS
Daiichi Sankyo
Johnson and Johnson
Covington
McKinsey

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078253

« Back to Dashboard
NDA 078253 describes ALLOPURINOL, which is a drug marketed by Watson Labs, Ipca Labs Ltd, Puracap Pharm, Mutual Pharm, Sun Pharm Inds, Superpharm, Apotex Inc, Northstar Hlthcare, Accord Hlthcare, Mylan, Indoco Remedies, Sandoz, Purepac Pharm, Sun Pharm Inds Inc, Vintage Pharms, and West-ward Pharms Int, and is included in twenty-five NDAs. It is available from forty-one suppliers. Additional details are available on the ALLOPURINOL profile page.

The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.

Summary for 078253

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antigout Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078253

Mechanism of ActionXanthine Oxidase Inhibitors

Suppliers and Packaging for NDA: 078253

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALLOPURINOL
allopurinol
TABLET;ORAL 078253 ANDA Northstar RxLLC 16714-041 16714-041-07 30 TABLET in 1 BOTTLE (16714-041-07)
ALLOPURINOL
allopurinol
TABLET;ORAL 078253 ANDA Northstar RxLLC 16714-041 16714-041-10 100 TABLET in 1 BOTTLE (16714-041-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Sep 11, 2007TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:Sep 11, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
QuintilesIMS
Novartis
Federal Trade Commission
Moodys
Deloitte
Merck
Argus Health
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot